Hall Capital Management Co. Inc. Has $2.06 Million Holdings in Intuitive Surgical, Inc. $ISRG

Hall Capital Management Co. Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 3,788 shares of the medical equipment provider’s stock after purchasing an additional 58 shares during the quarter. Hall Capital Management Co. Inc.’s holdings in Intuitive Surgical were worth $2,058,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Chilton Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the 1st quarter valued at $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the 1st quarter valued at $30,000. TD Capital Management LLC lifted its holdings in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new stake in Intuitive Surgical during the 1st quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $440.94 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The company has a market capitalization of $158.07 billion, a P/E ratio of 61.50, a P/E/G ratio of 4.71 and a beta of 1.61. The stock has a fifty day moving average of $461.55 and a 200-day moving average of $499.41.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter last year, the firm earned $1.78 earnings per share. The company’s revenue was up 21.4% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research reports. UBS Group raised their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a report on Wednesday, July 23rd. The Goldman Sachs Group cut their price target on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday, October 1st. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, BTIG Research reaffirmed a “buy” rating and set a $571.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 1st. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $589.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.